Wedbush Upgrades Replimune Group to Outperform, Raises Price Target to $19
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsUpgradesPrice Target
Wedbush analyst Robert Driscoll upgrades Replimune Group (NASDAQ:REPL) from Neutral to Outperform and raises the price target from $12 to $19.
Wedbush analyst Robert Driscoll upgrades Replimune Group (NASDAQ:REPL) from Neutral to Outperform and raises the price target from $12 to $19.